Vaxcyte, Inc. (NASDAQ:PCVX) Receives $65.00 Average PT from Analysts

Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have received an average rating of “Buy” from the six analysts that are currently covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have issued a report on the stock […]

Related Keywords

Jim Wassil ,Cantor Fitzgerald ,Nasdaq ,Capital Research Global Investors ,Vaxcyte Inc ,Needham Company ,Blackrock Inc ,Groupa Streptococcus ,Vanguard Group Inc ,Get Free Report ,Marketbeat Ratings ,Research Global Investors ,Get Free ,Vaxcyte Daily ,Vaxcyte ,Nasdaq Pcvx ,Pcvx ,Medical ,Ratings ,Consensus ,